BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16133362)

  • 21. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
    Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
    Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
    Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
    APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does CD10 immunoexpression have a diagnostic utility in the differential diagnosis of renal oncocytomas and eosinophilic variants of chromophobe renal cell carcinomas?
    Mete O; Kilicaslan I; Uysal V
    Pathology; 2009 Feb; 41(2):191-3. PubMed ID: 19152193
    [No Abstract]   [Full Text] [Related]  

  • 31. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining.
    Tickoo SK; Amin MB; Zarbo RJ
    Am J Surg Pathol; 1998 Apr; 22(4):419-24. PubMed ID: 9537468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
    J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms].
    Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.
    Langner C; Wegscheider BJ; Ratschek M; Schips L; Zigeuner R
    Virchows Arch; 2004 Feb; 444(2):127-34. PubMed ID: 14727107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrid chromophobe renal cell neoplasm.
    Mai KT; Dhamanaskar P; Belanger E; Stinson WA
    Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
    Sari ZB; Açikalin MF; Arik D; Özen A; Can C; Çolak E
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):534-540. PubMed ID: 33605572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases.
    Din NU; Fatima S; Ahmad Z
    Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.